Healthcare Law Update: September 2017

Published date06 September 2017
Law FirmHolland & Knight LLP
AuthorNathan Adams IV,Melissa Wong,Daniel Small,Andrew Namkung,Matthew Goldfarb,Michael Hantman
Subject MatterDOJ,HHS,CMS,Medicare,OIG,Anti-Kickback Statute,FDA,Retaliation,Expert Testimony,Appeals,Audits,Manufacturers,Qui Tam,Litigation Strategies,Health Insurance,Hospitals,Misrepresentation,Witness Preparation,Prescription Drugs,Reversal,EMTs,False Statements,Medicare Part D,Hip Replacement,Patient Safety,Health Care Providers,Product Defects,Medicaid Reimbursements,Anti-Steering Rules,FRCP 9(b),False Claims Act (FCA),Pharmaceutical Industry

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT